Raphael Pharmaceutical Inc. Net Change in Cash
Raphael Pharmaceutical Inc. (RAPH) reported Net Change in Cash of -$190.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2024-11-14
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $57.00K.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$250.00K.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$72.00K.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was -$85.00K.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$58.00K, a 142.96% decline from fiscal 2022.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $135.00K, a 132.76% increase from fiscal 2021.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $58.00K, a 28.89% increase from fiscal 2020.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $45.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$190.00K 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | -$110.00K 10-Q · filed 2024-08-12 | |||
| 2024-03-31 | $57.00K 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | -$58.00K 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $11.00K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | -$177.00K 10-Q · filed 2024-08-12 | |||
| 2023-03-31 | -$250.00K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $135.00K 10-K · filed 2024-03-28 | |||
| 2022-09-30 | -$60.00K 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$18.00K 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | -$72.00K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $58.00K 10-K/A · filed 2023-05-25 | |||
| 2021-09-30 | -$58.00K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $123.00K 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | -$85.00K 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $45.00K 10-K · filed 2022-03-30 | |||
| 2020-09-30 | -$14.00K 10-Q · filed 2021-11-16 |